• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Octreotide therapy for tumor-induced osteomalacia.

作者信息

Seufert J, Ebert K, Müller J, Eulert J, Hendrich C, Werner E, Schuüze N, Schulz G, Kenn W, Richtmann H, Palitzsch K D, Jakob F

机构信息

Division of Endocrinology, Metabolism, and Molecular Medicine, Medizinische Poliklinik, University of Würzburg, Germany.

出版信息

N Engl J Med. 2001 Dec 27;345(26):1883-8. doi: 10.1056/NEJMoa010839.

DOI:10.1056/NEJMoa010839
PMID:11756579
Abstract
摘要

相似文献

1
Octreotide therapy for tumor-induced osteomalacia.奥曲肽治疗肿瘤诱导的骨软化症。
N Engl J Med. 2001 Dec 27;345(26):1883-8. doi: 10.1056/NEJMoa010839.
2
Octreotide for tumor-induced osteomalacia.
N Engl J Med. 2002 May 30;346(22):1748-9; author reply 1748-9. doi: 10.1056/NEJM200205303462215.
3
Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia.生长抑素受体闪烁扫描术在肿瘤诱导性骨软化症治疗中的临床影响
Clin Nucl Med. 2008 Nov;33(11):752-6. doi: 10.1097/RLU.0b013e31818866bf.
4
Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia.靶向成纤维细胞生长因子受体阻断剂治疗肿瘤诱导的骨软化症
N Engl J Med. 2020 Oct 1;383(14):1387-1389. doi: 10.1056/NEJMc2020399. Epub 2020 Sep 9.
5
[Tumor-induced hypophosphatemic osteomalacia].肿瘤诱导的低磷性骨软化症
Nihon Naika Gakkai Zasshi. 2007 Apr 10;96(4):731-6. doi: 10.2169/naika.96.731.
6
[Detection of the primary tumor site in tumor-induced osteomalacia by indium-111 octreotide scintigraphy: a case report].[利用铟-111奥曲肽闪烁扫描术检测肿瘤性骨软化症的原发肿瘤部位：一例报告]
Rinsho Shinkeigaku. 2008 Feb;48(2):120-4. doi: 10.5692/clinicalneurol.48.120.
7
The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels.成人生长抑素受体瘤中生长抑素受体的水平不足以用其激动剂使血清磷酸盐水平正常化。
Calcif Tissue Int. 2010 Jun;86(6):455-62. doi: 10.1007/s00223-010-9369-9. Epub 2010 May 11.
8
Oncogenic osteomalacia: two case reports with surprisingly different outcomes.致癌性骨软化症：两例结局差异惊人的病例报告。
Arch Orthop Trauma Surg. 2009 Apr;129(4):533-9. doi: 10.1007/s00402-008-0808-2. Epub 2009 Jan 6.
9
Dual paraneoplastic syndromes: small cell lung carcinoma-related oncogenic osteomalacia, and syndrome of inappropriate antidiuretic hormone secretion: report of a case and review of the literature.双重副肿瘤综合征：小细胞肺癌相关的致癌性骨软化症及抗利尿激素分泌不当综合征：病例报告及文献复习
Hawaii Med J. 2011 Jul;70(7):139-43.
10
[Tumor-induced rickets/osteomalacia].肿瘤诱导的佝偻病/骨软化症
Nihon Rinsho. 2005 Oct;63 Suppl 10:523-8.

引用本文的文献

1
Clinical features and treatment of hypophosphatemia and associated complications induced by Phosphaturic mesenchymal tumors: A case series of six patients.磷尿性间叶肿瘤所致低磷血症及其相关并发症的临床特征与治疗：6例病例系列报告
Bone Rep. 2024 Dec 31;24:101822. doi: 10.1016/j.bonr.2024.101822. eCollection 2025 Mar.
2
F-AlF-NOTA-octreotide PET/CT in the localization of tumor-induced osteomalacia: case series and literature review.F-AlF-NOTA-奥曲肽 PET/CT 在肿瘤相关性骨软化症定位中的应用：病例系列和文献复习。
Front Endocrinol (Lausanne). 2024 Jun 3;15:1400751. doi: 10.3389/fendo.2024.1400751. eCollection 2024.
3
Spinal phosphaturic mesenchymal tumors: a rare etiology causing tumor-induced osteomalacia-a review of experience at a UK tertiary referral center and literature review.
脊柱磷酸盐尿性间叶性肿瘤：导致肿瘤性骨软化症的罕见病因——英国三级转诊中心的经验回顾和文献复习。
Eur Spine J. 2024 May;33(5):1911-1920. doi: 10.1007/s00586-023-08031-6. Epub 2023 Nov 14.
4
Phosphaturic mesenchymal tumor: two cases highlighting differences in clinical and radiologic presentation.磷酸盐尿性间叶性肿瘤：两例临床和影像学表现差异的病例报告。
Skeletal Radiol. 2024 May;53(5):995-1002. doi: 10.1007/s00256-023-04462-w. Epub 2023 Oct 4.
5
Phosphaturic Mesenchymal Tumor-induced Osteomalacia Masquerading as an Orthopedic Polytrauma Patient: A Case Report and Review of the Literature.伪装成骨科多发伤患者的磷尿性间叶肿瘤诱发骨软化症：一例报告并文献复习
J Orthop Case Rep. 2022 Nov;12(11):28-33. doi: 10.13107/jocr.2022.v12.i11.3402.
6
Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors.包括系统性成纤维细胞生长因子23静脉采样在内的多模态方法在定位磷尿性间叶肿瘤中的应用
J Endocr Soc. 2022 Nov 24;7(2):bvac181. doi: 10.1210/jendso/bvac181. eCollection 2022 Dec 15.
7
Head-to-Head Comparison of Ga-DOTA-TATE and Ga-DOTA-JR11 PET/CT in Patients With Tumor-Induced Osteomalacia: A Prospective Study.镓标记的DOTA-TATE与镓标记的DOTA-JR11 PET/CT在肿瘤性骨软化症患者中的头对头比较：一项前瞻性研究。
Front Oncol. 2022 Feb 24;12:811209. doi: 10.3389/fonc.2022.811209. eCollection 2022.
8
Tumor-induced osteomalacia: a case report.肿瘤诱导的骨软化症：一例报告
J Med Case Rep. 2022 Jan 12;16(1):22. doi: 10.1186/s13256-021-03220-7.
9
Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience.肿瘤诱导性骨软化症的诊断与管理：临床经验视角
J Endocr Soc. 2021 Jun 2;5(9):bvab099. doi: 10.1210/jendso/bvab099. eCollection 2021 Sep 1.
10
Comparison of F-FDG PET/CT and Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描与镓- DOTATATE 正电子发射断层扫描/计算机断层扫描在致佝偻病罪犯肿瘤靶向成像中的比较。
Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11.